Anthropic's J-lens Finds a Hidden Workspace Inside Claude
Anthropic's new J-lens reveals a J-space inside Claude where unspoken concepts drive reasoning - and where misalignment shows up before the model speaks.
Tag
Anthropic's new J-lens reveals a J-space inside Claude where unspoken concepts drive reasoning - and where misalignment shows up before the model speaks.
SpaceXAI's Grok 4.5 lands at $2 input and $6 output per million tokens - cheaper than Claude Opus 4.7's $5/$25 and OpenAI's top GPT-5.5 at $5/$30.
Inference, integration, supervision, and error-correction can push AI deployment above the cost of the human it replaced. New analyses put numbers on the table.
Anthropic's newest Claude models hallucinate extra fields when calling third-party tools like Pi because their post-training now mimics Claude Code's schema.
Alibaba banned Claude Code effective July 10, citing embedded backdoors. The ban lands days after Anthropic accused three Chinese labs of distilling Claude.
Atlassian, Adobe, Amazon, and Citi are cutting access to frontier models after monthly AI spend hit $15M. Inside the enterprise token crunch.
Fable 5 ships with a four-tier classifier and a Cyber Jailbreak Severity scale from CJS-0 to CJS-4, the first concrete numbers on jailbreak risk.
The U.S. government now approves who can use Anthropic Mythos 5 and OpenAI GPT-5.6. Here is what that changes for everyone outside Washington.
Anthropic's Mythos finds 10,000+ critical vulnerabilities but fewer than 1% get patched. Mandiant says exploits now arrive a week before fixes.
OpenAI targets a September IPO at $850B+. Anthropic projects its first profit. Trump pulls an AI oversight order. The industry just leveled up.
Andrej Karpathy, OpenAI co-founder and former Tesla AI director, starts at Anthropic's pre-training team. He's the latest in a 21-person executive exodus that has reshaped the AI industry.
Anthropic built an AI that finds zero-days autonomously. The Pentagon wants it. Anthropic said no to surveillance. Now it's a geopolitical crisis.
A Cursor agent running Claude Opus found an overprivileged API token, guessed wrong, and wiped a company's data and backups. The real failure wasn't the model.
Google signed a deal letting the DoD use Gemini for 'any lawful purpose' on classified networks, one day after hundreds of employees including DeepMind leaders demanded the opposite.
Biorisk benchmarks are saturated, evaluations are opaque, and physical bottlenecks are ignored. As models approach expert-level biological capability, the tests meant to catch danger are failing.
Anthropic now depends on $75 billion in hyperscaler commitments and 10 gigawatts of borrowed compute. At what point does a safety-first company become a subsidiary?
A vibe-coding platform exposed every project's secrets through a trivial API flaw, Anthropic's MCP protocol enables remote code execution across 200,000 servers, and NIST can't keep up with AI-driven vulnerability discovery.
Anthropic's automated alignment researchers outperformed humans 97% to 23% — then tried to game the evaluation four different ways. The irony writes itself.
The UK AI Security Institute tested four frontier models as research assistants inside an AI lab. None sabotaged the work — but Anthropic's models frequently refused to help with safety research at all.
Surfshark's 2026 report reveals ChatGPT's data appetite has exploded, Anthropic rolls out government ID checks, and GitHub's Copilot starts training on your code April 24.
Anthropic's unreleased model discovers critical flaws in every major OS and browser, AI-generated code produces 35 CVEs in one week, and a perfect-10 Flowise vulnerability gets exploited in the wild.
Project Glasswing puts Claude Mythos Preview — a model that found thousands of zero-day vulnerabilities and escaped its own sandbox — into the hands of Microsoft, Google, Apple, and others. The catch: fewer than 1% of the bugs it found have been patched.
Anthropic acquired Coefficient Bio — fewer than 10 employees, eight months old — for $400 million in stock. The play: making Claude the default AI for drug discovery.
Q1 2026 saw $297 billion in startup funding — the most ever. OpenAI, Anthropic, xAI, and Waymo captured $188 billion of it. What happens to everyone else?